Analytical Considerations Surrounding Extractables and Leachables Testing of Drug-Delivery Devices

Event Time

Originally Aired - Tuesday, November 29 3:30 PM - 4:15 PM

Info Alert

Create or Log in to My Show Planner to see Videos and Resources.

Videos

Resources

Create or Log in to My Show Planner to see Videos and Resources.


{{chatHeaderContent}}

{{chatBodyContent}}

Resources

Create or Log in to My Show Planner to see Videos and Resources.


Info Alert

This Session Has Not Started Yet

Be sure to come back after the session starts to have access to session resources.

Info Alert

You do not have access to videos and resources for this session.

Event Location

Location: Tech Theater


Event Information

Title: Analytical Considerations Surrounding Extractables and Leachables Testing of Drug-Delivery Devices

Description: Drug-delivery devices release a drug product over time into the human body. Depending on whether the product is intended to be submitted as a medical device or as a pharmaceutical drug product, the requirements for extractable and leachable (E&L) testing may differ. E&L testing for medical devices is typically defined as chemical characterization of medical device materials per ISO 10993-18. An E&L study for pharmaceutical drug products typically follows USP <1663> and <1664> for extractables and leachables associated with pharmaceutical packaging/delivery systems.

This presentation will overview E&L studies, comparing and contrasting E&L requirements between pharmaceutical products and medical devices. Key elements regarding E&L study design of drug-delivery products will be discussed. Case studies on the E&L testing of drug-delivery products will be presented, including implantable infusion pumps and prefilled syringes.

Type: Sponsored Session

Pass Type: Expo Floor Sessions & Events

Topic: Digital Health


Speakers


Sponsors


Notes

Create or Log in to My Show Planner to see Notes